Literature DB >> 23903553

Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.

Céline Damiani1, Solène Le Gal, Cécilia Da Costa, Michèle Virmaux, Gilles Nevez, Anne Totet.   

Abstract

This study assessed a quantitative PCR (qPCR) assay for Pneumocystis jirovecii quantification in bronchoalveolar lavage (BAL) fluid samples combined with serum (1→3)-β-d-glucan (BG) level detection to distinguish Pneumocystis pneumonia (PCP) from pulmonary colonization with P. jirovecii. Forty-six patients for whom P. jirovecii was initially detected in BAL fluid samples were retrospectively enrolled. Based on clinical data and results of P. jirovecii detection, 17 and 29 patients were diagnosed with PCP and colonization, respectively. BAL fluid samples were reassayed using a qPCR assay targeting the mitochondrial large subunit rRNA gene. qPCR results and serum BG levels (from a Fungitell kit) were analyzed conjointly. P. jirovecii DNA copy numbers were significantly higher in the PCP group than in the colonization group (1.3 × 10(7) versus 3.4 × 10(3) copies/μl, P < 0.05). A lower cutoff value (1.6 × 10(3) copies/μl) achieving 100% sensitivity for PCP diagnosis and an upper cutoff value (2 × 10(4) copies/μl) achieving 100% specificity were determined. Applying these two values, 13/17 PCP patients and 19/29 colonized patients were correctly assigned to their patient groups. For the remaining 14 patients with P. jirovecii DNA copy numbers between the cutoff values, PCP and colonization could not be distinguished on the basis of qPCR results. Four of these patients who were initially assigned to the PCP group presented BG levels of ≥100 pg/ml. The other 10 patients, who were initially assigned to the colonization group, presented BG levels of <100 pg/ml. These results suggest that the combination of the qPCR assay, applying cutoff values of 1.6 × 10(3) and 2 × 10(4) copies/μl, and serum BG detection, applying a 100 pg/ml threshold, can differentiate PCP and colonization diagnoses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23903553      PMCID: PMC3811637          DOI: 10.1128/JCM.01554-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Pneumocystis carinii trophozoites in the lungs of patients without pneumocystosis.

Authors:  G Nevez; S Delbecq; C Raccurt
Journal:  J Eukaryot Microbiol       Date:  1999 Sep-Oct       Impact factor: 3.346

2.  Molecular and serological evidence of Pneumocystis circulation in a social organization of healthy macaques (Macaca fascicularis).

Authors:  Christine Demanche; Fanélie Wanert; Mathieu Barthélemy; Jérôme Mathieu; Isabelle Durand-Joly; Eduardo Dei-Cas; René Chermette; Jacques Guillot
Journal:  Microbiology       Date:  2005-09       Impact factor: 2.777

3.  Use of a serum beta-glucan assay for diagnosis of HIV-related Pneumocystis jiroveci pneumonia in patients with negative microscopic examination results.

Authors:  Mary L Pisculli; Paul E Sax
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

4.  Use of a serum (1-->3)-beta-D-glucan assay for diagnosis and follow-up of Pneumocystis jiroveci pneumonia.

Authors:  María Soledad Cuétara; Almudena Alhambra; Fernando Chaves; María Dolores Moragues; José Pontón; Amalia del Palacio
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079

5.  Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Florence Persat; Stéphane Ranque; Francis Derouin; Annie Michel-Nguyen; Stéphane Picot; Annie Sulahian
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

6.  Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice.

Authors:  Paul J Christensen; Angela M Preston; Tony Ling; Ming Du; W Bradley Fields; Jeffrey L Curtis; James M Beck
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

Review 7.  Epidemiology and clinical significance of pneumocystis colonization.

Authors:  Alison Morris; Kenneth Wei; Kamyar Afshar; Laurence Huang
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

8.  Accuracy of a routine real-time PCR assay for the diagnosis of Pneumocystis jirovecii pneumonia.

Authors:  Judith Fillaux; Sonia Malvy; Muriel Alvarez; Richard Fabre; Sophie Cassaing; Bruno Marchou; Marie-Denise Linas; Antoine Berry
Journal:  J Microbiol Methods       Date:  2008-06-21       Impact factor: 2.363

9.  Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.

Authors:  J F Huggett; M S Taylor; G Kocjan; H E Evans; S Morris-Jones; V Gant; T Novak; A M Costello; A Zumla; R F Miller
Journal:  Thorax       Date:  2007-08-10       Impact factor: 9.139

10.  Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study.

Authors:  Yasuo Shimizu; Noriaki Sunaga; Kunio Dobashi; Makoto Fueki; Naoto Fueki; Sohei Makino; Masatomo Mori
Journal:  BMC Infect Dis       Date:  2009-04-22       Impact factor: 3.090

View more
  40 in total

1.  Performances of Four Real-Time PCR Assays for Diagnosis of Pneumocystis jirovecii Pneumonia.

Authors:  Milène Sasso; Elsa Chastang-Dumas; Sophie Bastide; Sandrine Alonso; Catherine Lechiche; Nathalie Bourgeois; Laurence Lachaud
Journal:  J Clin Microbiol       Date:  2015-12-30       Impact factor: 5.948

2.  Characterization of Pneumocystis jirovecii pneumonia at three tertiary comprehensive hospitals in southern China.

Authors:  Yan-Hui Chen; Xue-Yao Fang; Yue-Ting Li; Yan-Ling Liu; Ya-Ping Hang; Yan-Ping Xiao; Xing-Wei Cao; Qiao-Shi Zhong; Long-Hua Hu
Journal:  Braz J Microbiol       Date:  2020-05-03       Impact factor: 2.476

Review 3.  Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches.

Authors:  Marjorie Bateman; Rita Oladele; Jay K Kolls
Journal:  Med Mycol       Date:  2020-11-10       Impact factor: 4.076

Review 4.  Pneumocystis jirovecii pneumonia in patients receiving tumor-necrosis-factor-inhibitor therapy: implications for chemoprophylaxis.

Authors:  James A Grubbs; John W Baddley
Journal:  Curr Rheumatol Rep       Date:  2014-10       Impact factor: 4.592

5.  (1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.

Authors:  F Esteves; C-H Lee; B de Sousa; R Badura; M Seringa; C Fernandes; J F Gaspar; F Antunes; O Matos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-03       Impact factor: 3.267

6.  Serum and bal beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients.

Authors:  D Salerno; D Mushatt; L Myers; Y Zhuang; N de la Rua; E J Calderon; D A Welsh
Journal:  Respir Med       Date:  2014-11       Impact factor: 3.415

7.  Point-Counterpoint: Should Serum β-d-Glucan Testing Be Used for the Diagnosis of Pneumocystis jirovecii Pneumonia?

Authors:  Gabriela Corsi-Vasquez; Luis Ostrosky-Zeichner; Edward F Pilkington; Paul E Sax
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

8.  Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.

Authors:  Florence Robert-Gangneux; Sorya Belaz; Matthieu Revest; Pierre Tattevin; Stéphane Jouneau; Olivier Decaux; Sylviane Chevrier; Yves Le Tulzo; Jean-Pierre Gangneux
Journal:  J Clin Microbiol       Date:  2014-07-09       Impact factor: 5.948

9.  Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humans.

Authors:  Jayme L Dahlin; Theodore Kottom; Junhong Han; Hui Zhou; Michael A Walters; Zhiguo Zhang; Andrew H Limper
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

10.  Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC).

Authors:  Sean X Zhang; N Esther Babady; Kimberly E Hanson; Amanda T Harrington; Paige M K Larkin; Sixto M Leal; Paul M Luethy; Isabella W Martin; Preeti Pancholi; Gary W Procop; Stefan Riedel; Seyedmojtaba Seyedmousavi; Kaede V Sullivan; Thomas J Walsh; Shawn R Lockhart
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.